Ongoing disease activity and changing categories in a long-term nordic cohort study of juvenile idiopathic arthritis

Arthritis and Rheumatism

Volumn 63, Issue 9, 2011, Pages 2809-2818

  Nordal, Ellen ^a   Zak, Marek ^b   Aalto, Kristiina ^c   Berntson, Lillemor ^d   Fasth, Anders ^e   Herlin, Troels ^f   Lahdenne, Pekka ^c   Nielsen, Susan ^b   Straume, Bjørn ^g   Rygg, Marite ^h  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF TROMSØ   (Norway)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RITUXIMAB; SALAZOSULFAPYRIDINE;

ARTHRITIS; ARTICLE; CHILD; COHORT ANALYSIS; DENMARK; DISEASE ACTIVITY; FEMALE; FINLAND; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SCHOOL CHILD; SWEDEN;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; FINLAND; HUMANS; INCIDENCE; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; NORWAY; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052339614     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30426     Document Type: Article

References (45)

1. Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH,. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 3554-62. (Pubitemid 41612224)
2. Packham JC, Hall MA,. Long-term followup of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology (Oxford) 2002; 41: 1428-35. (Pubitemid 36004322)
3. Ringold S, Wallace CA,. Measuring clinical response and remission in juvenile idiopathic arthritis. Curr Opin Rheumatol 2007; 19: 471-6. (Pubitemid 47344240)
4. Bhopal R,. Concepts of epidemiology: an integrated introduction to the ideas, theories, principles and methods of epidemiology. Oxford University Press; 2002. p. 145.
5. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390-2. (Pubitemid 38160763)
6. Felici E, Novarini C, Magni-Manzoni S, Pistorio A, Magnani A, Bozzola E, et al. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. J Rheumatol 2005; 32: 1805-10. (Pubitemid 41324824)
7. Martini A, Lovell DJ,. Juvenile idiopathic arthritis: state of the art and future perspectives. Ann Rheum Dis 2010; 69: 1260-3.
8. Ravelli A, Felici E, Magni-Manzoni S, Pistorio A, Novarini C, Bozzola E, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum 2005; 52: 826-32. (Pubitemid 40365105)
9. Barnes MG, Grom AA, Thompson SD, Griffin TA, Luyrink LK, Colbert RA, et al. Biologic similarities based on age at onset in oligoarticular and polyarticular subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010; 62: 3249-58.
10. Ravelli A, Varnier GC, Oliveira S, Castell E, Arguedas O, Magnani A, et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011; 63: 267-75.
11. Berntson L, Andersson GB, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries: a population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 2003; 30: 2275-82. (Pubitemid 37221864)
12. Riise OR, Handeland KS, Cvancarova M, Wathne KO, Nakstad B, Abrahamsen TG, et al. Incidence and characteristics of arthritis in Norwegian children: a population-based study. Pediatrics 2008; 121: e299-306. (Pubitemid 351198435)
13. Andersson GB,. Juvenile arthritis: who gets it, where and when? A review of current data on incidence and prevalence. Clin Exp Rheumatol 1999; 17: 367-74.
14. Andersson GB, Fasth A, Andersson J, Berglund G, Ekstrom H, Eriksson M, et al. Incidence and prevalence of juvenile chronic arthritis: a population survey. Ann Rheum Dis 1987; 46: 277-81. (Pubitemid 17051215)
15. Zak M, Pedersen FK,. Juvenile chronic arthritis into adulthood: a long-term followup study. Rheumatology (Oxford) 2000; 39: 198-204. (Pubitemid 30139356)
16. Ruperto N, Ravelli A, Pistorio A, Malattia C, Cavuto S, Gado-West L, et al. Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries: review of the general methodology. Clin Exp Rheumatol 2001; 19: S1-9. (Pubitemid 33730178)
17. Andersson GB, Ruperto N, Berg S, Hagelberg S, Jonsson NO, Magnusson B, et al. The Swedish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19: S146-50. (Pubitemid 33730206)
18. Nielsen S, Ruperto N, Herlin T, Pedersen FK,. The Danish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19: S50-4. (Pubitemid 33730187)
19. Pelkonen P, Ruperto N, Honkanen V, Hannula S, Savolainen A, Lahdenne P,. The Finnish version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19: S55-9. (Pubitemid 33730188)
20. Selvaag AM, Ruperto N, Asplin L, Rygg M, Landgraf JM, Forre O, et al. The Norwegian version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ). Clin Exp Rheumatol 2001; 19: S116-20. (Pubitemid 33730200)
21. Nordal EB, Songstad NT, Berntson L, Moen T, Straume B, Rygg M,. Biomarkers of chronic uveitis in juvenile idiopathic arthritis: predictive value of antihistone antibodies and antinuclear antibodies. J Rheumatol 2009; 36: 1737-43.
22. Viola S, Felici E, Magni-Manzoni S, Pistorio A, Buoncompagni A, Ruperto N, et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. Arthritis Rheum 2005; 52: 2092-102. (Pubitemid 40994332)
23. Fries JF, Spitz P, Kraines RG, Holman HR,. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45. (Pubitemid 10164318)
24. Ware JE Jr, Sherbourne CD,. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
25. Landgraf JM, Abetz L, Ware JE,. The CHQ user's manual. Boston: The Health Institute, New England Medical Center; 1996. p. 235-9.
26. Wallace CA, Ruperto N, Giannini E,. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 2290-4. (Pubitemid 39453253)
27. Consolaro A, Ruperto N, Bazso A, Pistorio A, Magni-Manzoni S, Filocamo G, et al, for the Paediatric Rheumatology International Trials Organisation. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 2009; 61: 658-66.
28. Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M,. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002; 29: 1989-99. (Pubitemid 34988711)
29. Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Schontube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46: 2392-401.
30. Wallace CA,. Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010; 49: 1213-4.
31. Beresford MW, Cleary AG, Foster HE, Hutchinson E, Baildam EM, Davies K, on behalf of the UK MCRN/Arthritis Research UK Paediatric Rheumatology Clinical Studies Group and British Society of Paediatric and Adolescent Rheumatology. Comment on: Developing standards of care for patients with juvenile idiopathic arthritis [letter]. Rheumatology (Oxford) 2010; 49: 2227-9.
32. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silverman ED, Nocton JJ, et al, for the Pediatric Rheumatology Collaborative Study Group. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000; 342: 763-9. (Pubitemid 30151920)
33. Ruperto N, Lovell DJ, Cuttica R, Woo P, Meiorin S, Wouters C, et al. Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension. Ann Rheum Dis 2010; 69: 718-22.
34. Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al, for the Paediatric Rheumatology International Trials Organization and the Pediatric Rheumatology Collaborative Study Group. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum 2010; 62: 1792-802.
35. Shenoi S, Wallace CA,. Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review. Paediatr Drugs 2010; 12: 367-77.
36. Beresford MW, Baildam EM,. New advances in the management of juvenile idiopathic arthritisa: non-biological therapy. Arch Dis Child Educ Pract Ed 2009; 94: 144-50.
37. Hashkes PJ, Laxer RM,. Medical treatment of juvenile idiopathic arthritis. JAMA 2005; 294: 1671-84. (Pubitemid 41407360)
38. Solari N, Viola S, Pistorio A, Magni-Manzoni S, Vitale R, Ruperto N, et al. Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. Arthritis Rheum 2008; 59: 1571-9.
39. Oen K, Duffy CM, Tse SM, Ramsey S, Ellsworth J, Chedeville G, et al. Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort. Arthritis Care Res (Hoboken) 2010; 62: 527-36.
40. Hunter PJ, Nistala K, Jina N, Eddaoudi A, Thomson W, Hubank M, et al. Biologic predictors of extension of oligoarticular juvenile idiopathic arthritis as determined from synovial fluid cellular composition and gene expression. Arthritis Rheum 2010; 62: 896-907.
41. Barnes MG, Grom AA, Thompson SD, Griffin TA, Pavlidis P, Itert L, et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 2102-12.
42. Hollenbach JA, Thompson SD, Bugawan TL, Ryan M, Sudman M, Marion M, et al. Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects. Arthritis Rheum 2010; 62: 1781-91.
43. Knowlton N, Jiang K, Frank MB, Aggarwal A, Wallace C, McKee R, et al. The meaning of clinical remission in polyarticular juvenile idiopathic arthritis: gene expression profiling in peripheral blood mononuclear cells identifies distinct disease states. Arthritis Rheum 2009; 60: 892-900.
44. Jarvis JN, Jiang K, Frank MB, Knowlton N, Aggarwal A, Wallace CA, et al. Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2009; 60: 1488-95.
45. Kavanaugh A, Lee SJ, Weng HH, Chon Y, Huang XY, Lin SL,. Patient-derived joint counts are a potential alternative for determining Disease Activity Score. J Rheumatol 2010; 37: 1035-41.